Russell Investments Group Ltd. reduced its position in Bruker Corporation (NASDAQ:BRKR) by 5.7% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,538,145 shares of the medical research company’s stock after selling 93,393 shares during the quarter. Russell Investments Group Ltd. owned about 0.97% of Bruker Corporation worth $45,760,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of the company. Acrospire Investment Management LLC lifted its holdings in shares of Bruker Corporation by 496.1% during the second quarter. Acrospire Investment Management LLC now owns 3,827 shares of the medical research company’s stock worth $110,000 after purchasing an additional 3,185 shares during the period. SG Americas Securities LLC acquired a new stake in shares of Bruker Corporation during the second quarter worth $111,000. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in shares of Bruker Corporation by 11.3% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 4,599 shares of the medical research company’s stock worth $133,000 after purchasing an additional 467 shares during the period. Smithfield Trust Co. acquired a new stake in shares of Bruker Corporation during the second quarter worth $138,000. Finally, The Manufacturers Life Insurance Company lifted its holdings in shares of Bruker Corporation by 7.1% during the second quarter. The Manufacturers Life Insurance Company now owns 5,003 shares of the medical research company’s stock worth $144,000 after purchasing an additional 331 shares during the period. 66.27% of the stock is owned by institutional investors and hedge funds.

TRADEMARK VIOLATION WARNING: “Bruker Corporation (BRKR) Shares Sold by Russell Investments Group Ltd.” was originally posted by Daily Political and is owned by of Daily Political. If you are accessing this report on another site, it was illegally stolen and republished in violation of United States & international trademark & copyright law. The legal version of this report can be read at https://www.dailypolitical.com/2017/11/20/bruker-corporation-brkr-shares-sold-by-russell-investments-group-ltd.html.

A number of research firms have commented on BRKR. BidaskClub downgraded Bruker Corporation from a “buy” rating to a “hold” rating in a report on Wednesday, August 9th. Bank of America Corporation raised Bruker Corporation from an “underperform” rating to a “neutral” rating and set a $34.00 target price for the company in a report on Friday, November 3rd. Goldman Sachs Group, Inc. (The) reissued a “sell” rating and issued a $24.00 target price on shares of Bruker Corporation in a report on Tuesday, September 26th. J P Morgan Chase & Co raised Bruker Corporation from an “underweight” rating to a “neutral” rating and set a $28.00 target price for the company in a report on Friday, November 3rd. Finally, Cowen and Company reissued a “hold” rating and issued a $29.00 target price on shares of Bruker Corporation in a report on Friday, November 3rd. Two research analysts have rated the stock with a sell rating, ten have given a hold rating and four have assigned a buy rating to the company. Bruker Corporation has an average rating of “Hold” and an average target price of $29.64.

In other Bruker Corporation news, VP Mark Munch sold 21,061 shares of Bruker Corporation stock in a transaction dated Wednesday, September 13th. The stock was sold at an average price of $29.97, for a total value of $631,198.17. Following the completion of the sale, the vice president now owns 60,524 shares in the company, valued at approximately $1,813,904.28. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 35.20% of the stock is owned by insiders.

Shares of Bruker Corporation (NASDAQ BRKR) opened at $33.74 on Monday. The company has a market capitalization of $5,248.69, a PE ratio of 28.84, a P/E/G ratio of 2.85 and a beta of 1.05. Bruker Corporation has a 52-week low of $21.03 and a 52-week high of $35.16. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.60 and a current ratio of 2.60.

Bruker Corporation (NASDAQ:BRKR) last posted its quarterly earnings data on Thursday, November 2nd. The medical research company reported $0.29 EPS for the quarter, topping analysts’ consensus estimates of $0.27 by $0.02. The firm had revenue of $435.60 million during the quarter, compared to analysts’ expectations of $415.45 million. Bruker Corporation had a return on equity of 25.83% and a net margin of 8.85%. The firm’s quarterly revenue was up 10.6% compared to the same quarter last year. During the same quarter last year, the business posted $0.32 EPS. analysts expect that Bruker Corporation will post 1.19 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 22nd. Investors of record on Monday, December 4th will be given a dividend of $0.04 per share. This represents a $0.16 dividend on an annualized basis and a yield of 0.47%. The ex-dividend date is Friday, December 1st. Bruker Corporation’s dividend payout ratio is presently 17.02%.

Bruker Corporation Company Profile

Bruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions. Its segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment.

Institutional Ownership by Quarter for Bruker Corporation (NASDAQ:BRKR)

Receive News & Ratings for Bruker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.